We compared cellular proteins from normal human blood lymphocytes, monocytes, and granulocytes, using highresolution two-dimensional electrophoresis. The leukocytes were isolated from peripheral blood by centrifugation on density step gradients (yielding a fraction of purified granulocytes and a lymphocyte/monocyte mixture) and monocytes were subsequently separated from lymphocytes by virtue of their adherence to plastic. Wright-stained smears indicated that each of the three resulting fractions was 90 to 95% pure. The cells were labeled with [
major marker proteins of each type. The results are preliminary, in that further work, particularly of a quantitative nature [by use of the TYCHO system(7)], will be required to establish the relative specificities of the markers thus far identified and to identify minor ones.
Materials and Methods

Isolation and Separation of Lymphocytes, Monocytes, and Granulocytes from Peripheral Blood
The leukocytes were isolated from fresh ly drawn peripheral blood, collected by venipuncture into heparinized tubes (approximately 10 mL of blood per tube) from ostensibly normal persons. The whole-blood samples were centrifuged for] 5 min at 500 X g to obtain a buffy coat, and autologous plasma was heat-inactivated at 56°C for use in the growth medium.
Each buffy coat was diluted threefold in RPMI 1640 medium (GIBCO, Grand Island, NY 14672) and the lymphocytes, monocytes, and granulocytes were separated by gradient centrifugation in Ficoll-Paque gradients (Pharmacia Pine Chemicals, Piscataway, NJ 08854) with a cushion of 90% Percoll (Pharmacia) in phosphate-buffered sa line (CIBCO) . The two gradient bands (primarily lymphocytes and monocytes in the top band and granu locytes below) were washed in RPMI 1640 medium and residual erythrocytes were lysed by adding four volumes ofNH 4 CI solution (8.5 g-/L, pH 7.4). After erythrocyte lysis, the cells were washed in RPMI 1640 medium minus methionine (CISCO Selectamine Kit). Cell morphology was examined under oil immersion in Wrightstained smears of the two bands, and 200 or more cells from each gradient band were counted, to estimate t he purity of the cell preparations. The monocytes banded with the lymphocytes, and in five different preparations this band contained 90-95% lymphocytes plus monocytes and 5-10% granulocytes. The granulocyte band averaged 95% granul ocytes and 5% lymphocytes and monocytes.
Under the cu lture conditions we used, the granu locytes were viable for fewer than three days (as determ ined by f35SJme-thionine incorporation), whereas most of the lymphocytes were still viable at eight days (70% viable as assessed by the trypan blue exclusion technique). The leukocytes that attached to the well surface (monocyte/macrophages) did so during the 3rd to 6th day. During the first 48 h of cu lture these cells enlarged and formed clumps, which attached to the surface of the well. Some of these cells elongated and became fibrob lastic in appearance; others took on a "poac hed-egg" shape. The remaining leukocytes (the lymphocytes) stayed in suspension. No attached ce lls were seen in the granulocyte preparations.
Culture and Labeling of Leukocytes, and Preparation of Samples
Approximate ly 2 X 10 6 cells per well were cu ltured in flatbottomed multiwell plates in RPMI 1640 medium supplemented with, per liter, 200 mL of autologous human plasma, 4 X 10-5 mol of 2-mercaptoethanol, and antibiotics. They were incubated at 37°C in a humidified atmosphere of CO~/air (5/95 by vol). At the appropriate time, the suspended cells were centrifuged briefly-or, if the cells were attached, the medium was aspirated, and the adherent cells were washed in RPMI-minus-methionine medium (GIBeO Selectamine Kit). Then 400 ilL of labeling medium was added. The labeling medium consisted of RPMI 1640 medium minus methionine, containing, per liter, 50 mL of heat-inactivated autologous human plasma, 4 X 10-5 mol of 2-mercaptoethanol, antibiotics, and 60 mCi of [35S]methionine (spec. act., 1200 kCi/mol; Amersham , Arlington Hts., IL 60005), and the cultures were incubated for 18-24 h. At the end of the labeling period, the leukocytes were harvested and solubilized in an NP-40/urea mixture as previously described (7, 8) .
Solubilized proteins from the human lymphoblastoid B-cell line, GM607 (Human Genetic Mutant Cell Repository, Camden, NJ 08103; cultured as in ref. 9), the human myeloid leukemic cell line HL-60 (American Type Culture Collection, Rockville, MD 20852; cultured as in ref. 9) , and t he normal human skin fibroblast cell line 1494 (a gift from Meloy Laboratories, Inc., Springfield , VA 22151; NCI contract no. NOI-CP91000; cultured as in ref. 10) were analyzed in parallel with the three different leukocyte cell subpopulations.
Two-Dimensional Electrophoresis
We resolved the solubi lized proteins by high-resolution two-dimensional electrophoresis, using the ISO-DAL T system (II, 12) for the acidic and neutral proteins. The ISO gels used in the first dimension separation contained Servalyte 3.5-10 ampholytes (Serva Fine Biochemicals, Heidelberg, F.R.G.). Internal isoelectric point standards produced by carbamylation of rabbit-muscle creatine kinase (EC 2.7.3.2; Sigma Chemical Co., St. Louis, MO 63178) were used in all ISO gels (1 3). Linear gradient sodium dodecyl sulfate-slab gels (10-20% T) were used for the second-dimension separation. Gels were fixed, stained, dried, and autoradiographed or fluorographed (14) as described previously (7, 8) . Three to five preparations of the three leukocyte subpopulations from d ifferent donors have been compared, with similar results in each case.
Results
The two-dimensional gels of leukocyte subpopulations shown in Figure 1 typify the significant differences we saw in gene expression among lymphocytes, monocytes, and granulocytes, even though each of the three fractions were contaminated by 5-10% with cells of other types. Granulocytes appear to differ more from lymphocytes and monocytes than these two differ from each other, as might be expected in view of the limited lifespan of the granulocyte and its consequent commitment to the production of a small number of proteins related to its specialized function . Lymphocytes and monocytes nevertheless differ in the expression of a variety of specific marker proteins.
The principal lymphocyte markers (L:l through L:4; circles in Figure 1 ) are present in only trace quantities (probably the result of some contamination with lymphocytes) in monocyte and granulocyte preparations, and thus may represent true qualitative markers. Based on experiments with use of a cell sorter, it appears likely that L:l is a T-cell marker (K. E.
Willard , personal communication), rather than a general lymphocyte marker. The distribution of L:2-4 among lymphocyte subsets is currently under investigation.
The monocyte contains various specific proteins, many of which increase in relative abundance as the cells attach to the plastic of the tissue-culture vessel and become more macrophage-like. Although some of these markers (unlabeled boxes in Figure lC ) appear simply to be quantitatively more abundant in monocytes, some (M:1-7) appear specific enough to be considered qualitative markets. In addition, some spots identified as cell surface proteins (K. E. Willard, personal communication; S:I-4 in Figure lC ) are synthesized at a much higher rate in the attached monocytes than in either lymphocytes or granulocytes. A spot identified previously as a non-muscle tropomyosin (Cytosk:ll of ref. 10; labeled nmTm in Figure lC) is also increased in relative abundance in the attached monocytes.
The general rate of protein synthesis in granulocytes is substantially slower t han that in lymphocytes or monocytes. Thus, some proteins that are produced at a high rate relative to others in the granulocyte may not in fact be produced any faster than in the monocyte, in terms of synthesis per cell. However, at least six proteins appear to be genuinely induced in the granulocyte, and to show higher absolute as well as relative rates of synthesis in these cells. They include ( Figure  IE) Figure 1 ) are synthesized at substantially slower rates in the granulocyte, consistent with the limited life expectancy of this cell and the consequent lack of a need to regenerate most organelles.
Because the goal of this study is to identify candidate marker proteins for the three principal types of human blood leukocytes, it is important to investigate the appearance of these markers in the presumably more homogeneous cell populations grown as long-term-cultured cell lines. Figure 2 illustrates the results of such an investigation to survey the occurrence of the lymphocyte, monocyte, and granulocyte markers in a human B-Iymphoblastoid line (GM607) , a human promyelocytic leukemic line (HL-60), and a normal human fibroblast line (1494). The results, summarized in Table 1 , indicate that the candidate lymphocyte markers are generally more abundant in the lymphocytic and myeloid lines. An exception is L:l, whose absence from GM607 is consistent with its identification as aT-ceil marker. The monocyte, on the other hand, shares some of its markers (including an increased rate of synthesis of non-muscle tropomyosin) with the fibroblast. Some similarity between monocytes and fibroblasts might be expected because, of the cells examined here, only these two grow attached to the substrate. Nevertheless, it is interesting to note that the overproduction of surface proteins by monocytes (S:I-4) is not evident in the fibroblast; these proteins could be related to monocyte phagocytosis. The major granulocyte markers do not appear significantly in any of the cultured cell lines.
Discussion
We have identified here some protein markers characteristic of the three major types of peripheral blood leukocytes (lymphocytes, monocytes, and granulocytes) as prepared by classical physical methods. Aside from effects related to duration of culture, the results are comparable to those obtained by K. E. Willard et al. by use of cell-sorting methods (6; personal communication). The agreement of results by these two independent methods supports our conclusions as to the markers identified.
Information concerning cell type-specific markers is valuable in several contexts. In the first place, it allows immediate interpretation of some apparent "gene regulation" effects that in reality are the result of selective effects on subpopulations of cells. On treatment of human peripheral mononuclear cells with phorbol ester tumor promoters, for instance, several proteins are no longer seen in the two-dimensional pattern (4) . A group of these proteins is, in fact, the set of major monocyte markers; their disappearance may thus be simply the result . .
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(A) Lymphocytes (as in Fig. 1 A, but with more monocyte contamination, for comparison), (8) the human Iymphoblastoid 8-celiline GM607 , (C) the human promyelocytic leukemic cell line HL-60, (0) the normal human fibroblasl line 1494. Symbols indicating markers are the same as in Fig. 1 of selective toxicity of the compound in monocytes rather than a gene regulation effect in all the cells. A more important context may be the analysis of differentiation in the HL-60 cell line, where different compounds can be used to induce differentiation ' into either apparently mature monocytes or granulocytes (16) . Given a spectrum of markers, it is possible to determine whether the differentiation products of this leukemic cell line are genuinely mature in all respects, and whether the markers appear with similar or different time courses during the differentiation process. Some steps have recently been taken in this direction by Liebermann et aI. (17) , though without any investigation of time course or of the properties of the cell-type-specific markers. We believe that these markers will ultimately prove useful in the analysis of human leukemic cells.
The markers are also of considerable interest in terms of their expression in the established cell lines examined here. The absence of marker L:l from the B-lymphoblastoid cell line GM607 provides additional support for the notion (put forward by K. E. Willard, based on analogy with the mouse) 
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• Markers are as indicated in Figure 1 . Quantitation is based, at this stage, upon visual inspection of the fluorograms , and is thus only approximate.
that it is a T-cell-specific protein. Otherwise the proposed lymphocyte markers are abundant in the lymphoblastoid cells, nearly absent from fibroblasts, and (of particular interest) generally abundant in the promyelocytic leukemia ce ll line HL-60. This last result may indicate that t he lymphocyte markers described here are present in early stem cells of both myeloid and lymphoid lineages, but that the ir expression, whil e persisting in mature lymphocytes, is turned off in mature monocytes and granulocytes.
The observation of low amounts of most of the monocyte markers (as well as increased non-muscle tropomyosin synt hesis) in fibroblasts is also of interest in view of t he similar attached growth habits of the two cell types. Overall , the monocyte pattern is of course much more like that of a lymphocyte than a fibroblast (in keeping with the much closer lineage relationship between them) , and thus the monocyte markers (M:1-7) may be a set of proteins that is somehow involved in cell attachment. The lack of expression of the major monocyte surface proteins in fibroblasts shows, however, that not all the monocyte-specific proteins are simply related to attachment. It is interesting to speculate that these surface proteins are involved in phagocytosis, an activity at which the monocyte excels.
The identification and use of marker protein sets such as Rheumatoid arth ri tis is a chronic, systematic, inflammatory disease, predomina nt ly (b ut not excl usive ly) affecting the joints. The system ic nature of t he disease is characte rized by an increased erythrocyte sedimentatio n rate, hypochromic anemia, and t he appeara nce of characteristic anti -IgG antibodies, called " rheumatoid factors," in the serum. The sequence of immunologic events in rheum atoid arthri t is seems to begin with the production of rheumatoid fa ctors by synovial lymp hocytes. These antibodies are produced during a local immune response in the joint to unknown antigens (some of which may be a ltered forms of IgG).
Rheumatoid factor may be found within all immunoglobulin classes, but those detected in the circulation are primarily IgM. IgG from synovial t iss ue and effusions of patients with rheumatoid arthritis has been shown to be present in immune comp lexes that initiate t he loca l inflammatory process that causes rheumatoid disease, and to perpetuate and ampli fy the pathological changes t hat occu r in the joint (I , 2). Ci rculating rheumatoid factors are detectable ill only 60-70% of patients with the disease, and a distinction is therefore made between "seropositive" a nd "seronegative" forms of the disease. The d eter mination of rheumatoid factor is use ful for diagnostic purposes, because there is a positive correlation between its titer in serum and disease seve ri ty. T he nature of the destructive process in t he joint is not entirely clear, but it is thought to be mediated by enzymes released from t he lysosomes of the synovial ce lls, granulocytes, and macrophages in the hyperpl astic synovial membra ne. Ristori et al. (3) a nalyzed membrane markers of synovia l and peripheral blood lymphocytes from rheumatoid arthritis patients but were un a ble to detect population differences between rheumatoid arthritis patients and controls. However, using ce ll electrophoresis, Brown et 
T he systematic analysis of approximately 1000 leukocyte prote ins fr om patients with rheumatoid arthritis by twodimensional polyacrylamide gel electrophoresis was undertaken to investigate the possibility of abnormal protein synthesis, post-translational modification, and (or) gene regulationin the immune cells of these individuals. Peripheral blood leukocytes were chosen for this initial study because of the routine nature of sample acq uisition from both patients and co ntrols. This analysis includ ed blood samples from 120 volunteer patients with rheumatoid arthritis. In addition to healthy volunteer individuals, patients with an kylosing spondylitis, poly myalgia rheumatica, psoriatic arthritis, tendini t is, post -infectious arthritis, and asymmetrical seronegative arthritis were included as positive cont rols. The two-d imens ional ge l analysis was performed without knowledge of the clinical diagnosis or review of patients' test resul ts; however, after the initia l grouping the interpretation of the data was correlated with clini ca l findings. This is the first large-sca le clinical study performed with use of the ISO-DALT technique (6, 7) for two-d imensional gel analysis. A group of proteins, referred to as the "Rheuma set," a ppear to be indicato rs of rheumatoid a rthri t is disease activity.
Materials and Methods
Isolation of Leukocytes
All ex periments were performed on human peripheral blood leukocytes from patients with classical rheumatoi d arthritis (Am. Rheumatism Assoc. criteria), ankylosing spondylitis, polymyalgia rheumatica, pso riatic arthritis, tendinitis, postinfectious arthritis, or asym metrica l seronegative art hritis, and from normal donors. The patients were all under the care of a rheumatologist in Oslo, Norway.
Peripheral blood (10 mL) was co llected by venipuncture into he parinized tubes, equilibrated on a rocker panel until a ll sampl es were coll ected, and then ce ntrifuged for 15 min at 500 X g to obtain buffy coats. Buffy coat leukocytes we re diluted threefold in RPM} 1640 medium (Flow Laboratories, Irvine KA1 2 8N B, Scotland) , and the lymphocyte fraction (al so conta ining monocytes and a small percentage of contaminating granu locytes) was iso lated by Ficoll-Paque gradient centrifugation (Pharmacia Fine Chemicals AB, Uppsala, Sweden). Enriched lymphocyte bands (referred to here as leukocytes) were washed twice in RPMI 1640 medium and then finally washed in RPMI 1640 containing no methiOlfine (Select-amine kit; GIBCO, Grand Island , NY 14672).
Labeling of Leukocyte Proteins
Leukocytes were cultured in flat-bottomed , multi-well plates at concentrations of up to 4 X 10 6 cells per well in a total volume of 400,uL. Cells were cultured in RPMI 1640 labeling medium (which contains no methionine) supplemented with fetal bovine se rum (50 mL/L), 2-mercaptoetha nol (4 X 10-5 mol/L), and 25-50 ,uCi of [:35S]methionine (spec. acty. 1420 kCi/mol; Amersham International Ltd., Amersham, Buckinghamshire HP7 9LL, England). Cultures were incubated at 37 °C in a humidified atmosphere containing five volumes pfC02 per 100 volumes, for 18 h urless otherwise indicat.ed.
Two-Dimensional Polyacrylamide Gel Electrophoresis
A t the end of the labeling period, leukocytes were harvested by brief centrifugation ip a microcentrifuge (Beckman Microfuge B; Beckman Instruments, Palo Alto, CA 94304), and the cell pellets were lysed in a buffer containing, per liter, 40 mL of Nonidet P40 detergent, 9 mol of urea, 20 mL of amphoJytes (Ampholines; LKB Instruments, Bromma, Sweden), and 50 mL of 2-mercaptoethanol. Solubilized samples were centrifuged in the microcentrifuge for 1 min to sediment the insoluble material. The soluble proteins were analyzed by highresolution two-dimensional electrophoresis (ISO-DAL T system, 6, 7) to resolve the acidic and neutral proteins. The ISO gels used in the first-dimension separation contained pH 3.5-10 Ampholines (LKB Instruments). Internal isoelectric-point standards, produced by cal'bamylation of rabbit muscle creatine kinase (EC 2:7.3.2; Sigma Chemical Co., St. Louis, MO 63178), were used in all ISO gels (8) . Second-dimension separations were perfomed on a linear-grad ient 100-200 giL polyacrylamide gel. Gels were fixed , dried, and autoradiographed for one to two weeks as des~r ibed previously (9) .
At least two normal controls were used every time a patient's blood samples were examined. Figure 1 illustrates the alterations detected in two-dimensional gel autoradiographs of human leukocyte proteins from patients with rheumatoid arthritis. Figure 1A shows an autoradiograph of leukocyte proteins from a normal individual, and Figures IB and Ie represent typical rheumatoid patterns.
Results
Alterations in Leukocyte Protein Synthesis in Rheumatoid Arthritis
The synthesis of several proteins (determined by t he in corporation of [35S] methionine) increases, and some proteins not seen before appear in the leukocyte preparations from patients with rheumatoid arthritis. These proteins (indicated in Figure  1 by the letter R) are referred to by number as members of the "Rheuma" set under the set-naming conventions discussed previously (10) .
Rheuma:1 has been shown to be a monocyte marker protein by fluorescence-activated cell sorting with use of the monoclonal antibody OKM.l and su bsequent two-dimensional gel analysis of the purified monocyte proteins (K. E. Willard et aI. , manuscript in preparation).
Ge l analysis of granulocytes purified on the basis of rightangle light scatter ing by use of t he cell sorter indicates that Rheuma:3 is a major granulocyte marker protein, although small amounts can be detected in monocytes as well.
Rheuma:4 and Rheuma:5 have not been detected before this analysis of rheumatoid arthritis leukocyte proteins, and therefore may be unique markers of t.he disease. It is not 1068 CLINICAL CHEMISTRY, Vol. 28, No. 4, 1982 possible to ass ign a cell lin eage to the origin of Rheuma:4-5 until leukocytes from patients with active rheumatoid arthritis can be purified by using fluorescence-activated cell sorting analysis.
Rheuma:6-7 are present in granulocytes, monocytes, and lymphocytes; however, their relative abundances vary: granulocytes contain more than ten times the quantity in monocytes, anp monocytes more than twice the amount present in lymphocytes. Rheuma:6-7 are phosphorylated, as demonstrated by 32P-Iabeling studies (N. Leigh Anderson, personal comm unication) . A collaborative analysis has also revealed that Rheuma:6-7 are the same as the L, protein described by Fagherol et al. (Il, 12) .
The leukocyte proteins from the two pati ents with active rheumatoid arthritis ( Figures IB and Ie) are representative of the pattern seen for this disease as q)mpared with an agematched control (Figure lA) . Patient OS-2 ( Figure IB) is a 56-year-old woman who had not responded to treatment. At the time the blood sa mple was taken the sedimentation rate was 110 mm/h and the leukocyte count was 14 500/mm:!. She had strong seropositive rheumatoid arthritis wi th a WaalerRose titer of 1000. At the time of our analysis her cond iti on was deteriorating, and it did not improve when she was treated with penicillamine.
Patient OS-5 ( Figure Ie) , a 69-year-old man, was first diagnosed with rheumatoid arthritis one year before the blood sampling for two-dimensional gel analysis. At the time of sample acquisition the sedimentation rate was 82 mm/h and the leukocyte count was 7900/min:!. He also has strong seropositive rheumatoid arthritis with a Waaler-Rose titer of 2000. Therapy with prednisolone (:30 mg/day) and D-penicillamine (250 mg/ day) was begun one month before our samp li ng, but the patient was only beginning to respond to these drugs at the time of our sam pling. Figure 2 shows sections of two-dimensional gel autoradiographs of leukocytes from a normal donor (A) and patients with classical rheumatoid arthritis (B), post-infectious arthritis (e), ankylosing spondylitis (D), poly myalgia rheumatica (E), and psoriatic arthritis (F) .
Comparison of Leukocyte Proteins from a Variety of Arthritis Patients
Patient OS-40 ( Figure 2B ), a 60-year-old ma n, had just started to respond to treatment with gold thiomalate (Myocrisin R; May and Baker, Inc., England) at the time our sample was taken for ana lysis. The sedimentation rate was 57 mm/h and the leukocyte count was 7000/mm:~. The patient had seropositive rheumatoid arthritis, with a Waaler-Rose titer of 250 and he demonstrated the increased amounts of Rheuma:l, :3, and :6-7 that see m to be characteristic of classica l rheumatoid arthritis. In addition , the markers Rheuma:4-5 are also present in this leukocyte pattern, as they were in all samp les from patients with active rheumatoid arthritis.
Although a definitive diagnosis was not possible on pati ent OS-38 (Figure 2e) , a 24-yea r-old woman, the tentative diagnosis is post-infectious arthritis. This patient demonstrated arthritis in one knee and had cystitis in the initial stageR ofthe disease, wh ich began with general anorexia apd joint pain. The sample taken for two-dimensiona l gel analysis was acquired early in the disease when the sed imentation rate was :tl mm / h. She was seronegative t.o the Waa ler-Rose test. The prot ein pattern shows a slight increase in Rheuma:1, :~, and :6-7 over the control sa mple (but less than half the increase see n in 08-40) . In addit.ion, a sma ll amount (lC Rhellmn:4 was detected. Rheuma:5 is diminished in this protein patte rn .
Patient OS-4 1 ( Figure 2D) , a :12-ypar-olcl man. has allkylosing spondyli tis. il chron ic inflammatory di~il!o'e affect in g' ..,.
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.. Figure 1 the sacroiliac joints and the spine"At the time of sample acquisition for two-dimensional gel analysis, the sedimentation rate was 10 mm/h and the leukocyte count was 4000/mm 3 . The relative amounts of Rheuma:1 , :3, and :6-7 in this protein pattern are esseritially identical to those in the control pattern, and Rheuma:4-5 were barely detectable. Figure 2E shows the pattern for a 71-year-old man (Patient 08-30) with polymyalgia rheumatica, a poorly understood muscular disease. This condition is characterized by muscle pain with the absence of inflammatory arthritis, but the erythrocyte sedimentation rate is much increased during the active phase. Patient 08-30 had been responding to a high dose of prednisolone, which r~lieved the symptoms and decreased the sedimentation rate to near-normal values, The sample taken for analysis was obtained after the dose of corticosteroids had' been decreased to 5 mg of prednisolone per day and the sedimentation rate had declined to 12 tnm/h. were approximately the same as in the normal donor ( Figure   2A ).
Patient 08-37 ( Figure 2F ) was a 22-year-old man with seronegative psoriatic arthritis, At the time the blood sample was taken, the sedimentation rate was 36 mm/h and the leukocyte count was 8000/mm 3 , Comparison of his two-dimensionalleukocyte pattern with an age-matched control demonstrated that the amounts of Rheuma:1, :3, and :6-7 were not significantly increased and that Rheuma:4-5 were not detectable. ..
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indicators of rheumatoid arthritis disease activity, and therefore we compared two patients, one with active rheumatoid arthritis and one whose disease had improved and stabilized on penicillamine ( Figure 3) . Figure 3A shows a section from a two-dimensional gel autoradiograph of leukocyte proteins from a normal donor. Figure 3B shows the pattern for an 83-year-old woman (Patient 08-24) who has had classical symptoms of rheumatoid arthritis for longer than 30 years. 8he improved on penicillamine in recent years and was in a stable condition with very little disease activity at the time the sample illustrated was taken for two-dimensional gel analysis. At this time, the sedimentation rate was 37 mm/h and the leukocyte count was 7400/mm 3 . On the other hand, Patient 08-23 ( Figure 3C ), a 57-year-old woman, had classical rheumatoid arthritis in a very active phase at the time the sample was collected. 8he has seropositive rheumatoid arthritis, with a Waaler-Rose titer of 300. At the time the blood sample was taken for two-dimensional gel analysis, the sedimentation rate was 80 mm/h and the leukocyte count was 15 400/mm 3 . The patient had previously been treated with gold, but it had not improved her condition, and she was just beginning a course on D-penicillamine when we obtained the sample.
The differences in the amounts of Rheuma: 1, :3, and :6-7 are readily apparent in the patterns shown in Figures 3B and  3C . There is at least a twofold d ifference in the quantity of these proteins between the control sample and the patient with inactive disease (08-24) and another twofold increase in the amount of protein synthesized by the leukocytes from the patient with active disease (-08-23). In addition, only in Patient 08-23 were Rheuma:4-5 detectable, strengthening the argument that these are novel proteins in patients with active rheumatoid arthritis. Rheuma:2, like Rheurna:4-5, appears to be detectable only in patients with active disease. Although Rheuma:2 was not detected in the patterns shown in Figures 1 and 2 , it was found in the patterns shown in Figure  3 . The patterns in Figures 1 and 2 were obtained (by the same individuals) with the ISO-DALT apparatus in the Molecular Anatomy Program at Argonne; the patterns in the third figure were obtained with the commercial version of the ISO· DALT apparatus, at the Rikshospitalet in Oslo. We attribute the apparent shift in the molecular mass of Rheuma:3 and the appearance of Rheuma:2 to subtle differences in the brands of sodium dodecyl sulfate used in the gels.
Discussion
It has become increasingly apparent that alterations in the regulation or synthesis of proteins can be implicated in the pathogenesis of a variety of clinical disorders. It is possible to study the synthesis of hundreds of proteins or protein subunits by radiolabeling cellular proteins and subsequently analyzing them by two-dimensional polyacrylamide gel electrophoresis (13) . It has also been demonstrated that such a two-dimensional analysis can be used to study regulation events within the cell (10, 14) . Recent investigations have revealed differences in the two-dimensional patterns of leukocytes from patients with infectious mononucleosis (15), leukemia (K. E. Willard et aI., manuscript in preparation), intestinal biopsies (16) , and muscle biopsy samples from patients with a number of muscular diseases (J 7). Thus we undertook systematic analysis of leukocytes from 120 patients with rheumatoid arthritis and 30 controls, with t he idea of surveying their protein patterns for abnormally synthesized proteins, which might then be implicated in the disease.
The purpose of this large-scale protein analysis of cells involved in the rheumatoid inflammatory reaction was to find indicator proteins that are either abnormally abundant or diminished in leukocyte patterns from patients with active 1072 CLINICAL CHEMISTRY, Vol. 28, No. 4, 1982 disease. Ultimately, these target proteins might be used as markers in the diagnosis of rheumatoid arthritis by twodimensional gel analysis or other techniques such as radioimmunoassay. However, the technique has not yet been automated or mechanized to the point where it can be used as a routine clinical tool, nor has a sufficiently large data base been built to support the diagnosis of human disease by twodimensional gels. In addition, alterations in the relative numbers of granulocytes that sediment with the lymphocytes and monocytes in the top layer of a Ficoll-Paque gradient can affect results of this type of analysis. However, at the present time, two-dimensional gels are an excellent research tool and as such provide a means for targeting proteins that might be implicated in a particular disease.
The initial gel screen was undertaken as a blind study without the analysts' knowledge of the clinical diagnosis or a review of the patients' test results. This allowed us, first to derive our conclusions without prejudice and subsequently to correlate our findings with conclusions drawn from established clinical criteria. The results described here have demonstrated consistent alterations in the two-dimensional protein patterns obtained from Ficoll-P~que-isolated leukocyte populations of rheumatoid arthritis patients. These proteins, referred to by number as members of the Rheuma set, increase at least fivefold in patients with active rheumatoid arthritis as compared with patients with ankylosing spondylitis, polymyalgia rheumatica, psoriatic arthritis, tendinitis, or asymmetrical seronegative arthritis. Patterns from patients with post-infectious arthritis often show slightly increased amounts of the Rheuma proteins, implying that an increase in these proteins may be characteristic of inf1ammatory arthritis. In accordance with this, patients with polymyalgia rheumatica who have a high sedimentation rate but no inflammatory arthritis do not have increased amounts of the Rheuma proteins.
The analysis of leukocyte sub populations by fluorescence-activated cell sorting coupled with two-dimensional polyacrylamide gel electrophoresis (K. E. Willard et a!., manuscript in preparation) has demonstrated that Rheuma:l is a monocyte protein, while Rheuma:3 and :6-7 are found in both monocytes and granulocytes, with a greater abundance of these proteins characteristic of granulocytes. The cellular origin of Rheuma:2 and :4-5 has not been definitively determined by our initial analysis of the human leukocyte subpopulations, but preliminary data suggest that they are of monocytic origin.
Differential leukocyte counts on peripheral blood from rheumatoid arthritis patients did not differ significantly from the controls (averaging about 6% monocytes, 50% granulocytes, and 30% lymphocytes in both). Therefore, it is unlikely that the increase in the Rheuma proteins is simply due to a general increase in monocytes or granulocytes in the peripheral blood. Future analyses will include differential counts on the harvested cell populations to determine the exact ratio of monocytes, granulocytes, and lymphocytes in the cell populations being labeled. The increase in granulocyte proteins could be caused by alterations in the cells themselves that affect their behavior on a Ficoll-Paque gradient and increase the number of granulocytes contaminating the top layer of the gradient. 8uch contamination would not account for the increased synthesis of monocyte-specific proteins, because monocytes normally sediment with lymphocytes in our gradients, and the number of monocytes in the blood of arthritis patients was not seen to differ significantly from control values. An alternative explanation lies in the nature of the disease process itself. Although rheumatoid arthritis is not well understood, it is thought that monocyte, granulocyte, and synovial cell enzymes are released in the joint and mediate its destruction. An increase in the synthesis of specific proteins from these cell types could be a reflection of this phenomenon.
The work described here is presented as a preliminary analysis of rheumatoid arthritis with two-dimensional gels, to determine whether altered protein synthesis in patients' leukocytes could be implicated in the disease. Future work must include an analysis of purified leukocyte subpopulations from patients and controls with use either of cell sorting or in vitro culturing techniques, to examine directly the specificity of the Rheuma proteins as well as to determine whether their synthesis is being selectively regulated as a manifestation of the disease. In addition, this type of analysis would provide information about the cellular origin of Rheuma:2 and :4-5 and further evidence to determine whether they are in fact characteristic of leukocytes from patients with rheumatoid arthritis or perhaps represent more general inflammatory arthrit is.
